European Parliament

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
20 March 2013
E-003144-13
Question for written answer
to the Commission
Rule 117
Claudiu Ciprian Tănăsescu (S&D)

 Subject:  Triclosan: an endocrine disruptor used in toothpaste
 Answer(s) 

The recently adopted European Parliament resolution of 14 March 2013 on the protection of public health from endocrine disrupters (2012/2066(INI)) explains the risks posed by chemical pollutants to the endocrine/hormonal systems of humans and why it is urgent for the Commission to come forward with an ambitious and adequate EU strategy on endocrine disruptors. It has been clearly underlined by MEPs, as well as in the recent WHO report, that children and pregnant women, as vulnerable sectors of the population, have to be given greater attention and more protection as regards chemical pollutants.

On the other hand, the recent debates in Denmark regarding the antibacterial chemical Triclosan highlight the risk of using one of the most common toothpastes in the world. The Danish Minister of the Environment intends to ban this toothpaste on the basis of studies indicating that the use of this specific substance can cause antibacterial resistance.

What is the Commission’s position with regard to the presence of Triclosan in the composition of toothpastes?

Does it intend to take any measures with regard to this problem?

 OJ C 11 E, 15/01/2014
Last updated: 10 April 2013Legal notice